Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19

Juan Corchado-Garcia, David Puyraimond-Zemmour, Travis Hughes, Tudor Cristea-Platon, Patrick Lenehan, Colin Pawlowski, Sairam Bade, John C. O’Horo, Gregory J. Gores, Amy W. Williams, Andrew D. Badley, John Halamka, Abinash Virk, Melanie D. Swift, Tyler Wagner, Venky Soundararajan
doi: https://doi.org/10.1101/2021.04.27.21256193

Data Availability

After publication, the data will be made available upon reasonable requests to the corresponding author. A proposal with detailed description of study objectives and the statistical analysis plan will be needed for evaluation of the reasonability of requests. Deidentified data will be provided after approval from the corresponding author and the Mayo Clinic.

Back to top
Posted April 30, 2021.
Download PDF
Data/Code
Email
Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19
Juan Corchado-Garcia, David Puyraimond-Zemmour, Travis Hughes, Tudor Cristea-Platon, Patrick Lenehan, Colin Pawlowski, Sairam Bade, John C. O’Horo, Gregory J. Gores, Amy W. Williams, Andrew D. Badley, John Halamka, Abinash Virk, Melanie D. Swift, Tyler Wagner, Venky Soundararajan
medRxiv 2021.04.27.21256193; doi: https://doi.org/10.1101/2021.04.27.21256193
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area